AbbVie Inc. buy Joe130978
Start price
09.12.22
/
50%
€156.72
Target price
09.12.23
-
Performance (%)
-11.18%
End price
10.12.23
€139.20
Summary
This prediction ended on 10.12.23 with a price of €139.20. The price of AbbVie Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.18%. A total of €5.43 was paid as dividends for this prediction. Joe130978 has 50% into this predictionAbbVie (ABBV) is a multinational biopharmaceutical company based in North Chicago, Illinois. It was spun off as a separate entity from Abbott Laboratories in 2013 and is primarily focused on the development and commercialization of drugs for the treatment of conditions such as immunology, oncology, and neuroscience. Its key product is Humira, which is used to treat a range of autoimmune diseases, generating a significant portion of the company's revenue. The company also has a pipeline of promising products in various stages of development, making it a reputable player in the pharmaceutical industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AbbVie Inc. | -0.909% | -0.909% | 6.410% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% |
Comments by Joe130978 for this prediction
In the thread AbbVie Inc. diskutieren
Joe130978 hat das Wertpapier AbbVie Inc. in seinem Wikifolio Die ganze Welt der Biotechs gekauft.
In the thread Trading AbbVie Inc.
Die von Joe130978 gewählte maximale Laufzeit wurde überschritten